Prominent journalist and activist Hopewell Chin’ono has brokered a deal with a British pharmaceutical company to provide life-saving antiretroviral (ARV) drugs to Zimbabweans for just £5 per month.
This humanitarian gesture, which covers only the company’s administrative fees, comes after the abrupt cessation of American aid funding for ARVs, leaving over 1.3 million Zimbabweans living with HIV at risk.
Chin’ono confirmed he had contacted the Zimbabwean Permanent Secretary for Health to expedite the offer and prevent delays. Leading HIV specialist Professor Rati Ndhlovu has warned that without immediate action, “Zimbabweans carrying the virus will die.”
The deal is seen as a lifeline amid growing fears of corruption. Chin’ono made the offer public to prevent exploitation by “tenderpreneurs” who have been known to inflate prices for personal gain. “We cannot let this crisis be exploited for profit. Zimbabweans should not die from AIDS when a solution is available,” he said.
RELATED NEWS
- Cost of Living Crisis in Zimbabwe: You Need ZIG 861.14/Day to Survive
- Walter Magaya Exposed: UNISA Confirms Diploma Forgery
- Why Video Marketing Matters for Zimbabwean Small Businesses
- WATCH : Chiwenga Criticizes Corrupt ”Mbingas” and Urges Fair Access to Opportunities
- Activist Tafadzwa Rusere Arrested for Illegal Cocaine Possession
- What Potential University Students Must Know: Psychologist vs Psychiatrist
- AFCON 2025 Draw: Excitement Builds as Teams Learn Their Fate
- Wicknell Chivayo Talks Clean Energy, Vision 2030 at Pre-Summit Meeting with President Ruto
The crisis underscores the fragile state of Zimbabwe’s healthcare system, with clinics and hospitals already struggling to secure alternative supplies. Without treatment, HIV can progress to AIDS, which is often fatal.
Chin’ono’s move has drawn widespread praise, but experts caution that bureaucratic delays could derail the deal. Families are being urged to check with their clinics about ongoing medication availability.
As Zimbabwe faces mounting economic and healthcare challenges, Chin’ono’s efforts offer hope, but swift action is essential to ensure this opportunity saves lives.
